Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
ELECTRON TRANSPORT CHAIN | 1 μM | human | NCI-60 cell lines, F0F1-ATPase | decrease | IC50 | 154 | ||
ELECTRON TRANSPORT CHAIN | 0.4 μM | S. cerevisiae | membrane-bound F0F1-ATPase | decrease | Ki | 161 | ||
APOPTOSIS | 1 μM | 60 human cancer cell lines of the National Cancer Institute | mean | 184 | ||||
Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
ATP synthase | 1 μM | human | NCI-60 cell lines, F0F1-ATPase | inhibitor | IC50 | 154 | ||
ATP synthase | 0.4 μM | S. cerevisiae | membrane-bound F0F1-ATPase | inhibitor | Ki | 161 | ||
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LDLo | intraperitoneal | 3130ug/kg (3.13mg/kg) | Journal of Antibiotics. Vol. 34, Pg. 1073, 1981. | |
79553-45-0 | BRN 4226438 | Cytovaricin |
H-230 | LS-59152 | NSC 349622 |